Atlas Trials

A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects

Clinical trial NCT02760758 · COMPLETED

Trial details

NCT number
NCT02760758
Sponsor
Cocrystal Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C
Start date
2016-04-01
Primary completion
2017-03-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.